Gene Therapy Makes Inroads Against a Form of Hemophilia
FRIDAY, July 22, 2022 (HealthDay News) — People with hemophilia B could find their bleeding risk dramatically reduced with just one injection of an experimental gene therapy, a new study reports. Hemophilia B is a rare and inherited genetic disorder in which people have low levels of the factor IXContinue Reading